<Record>
<Term>gp100 Vaccinia Vaccine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Immunologic Factor</SemanticType>
<ParentTerm>Vaccinia Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Vaccinia Vaccine/gp100 Vaccinia Vaccine</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Vaccinia Vaccine</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>gp100 Vaccinia Vaccine</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>gp100 Vaccinia Vaccine</Synonym>
<Description>A cancer vaccine consisting of a recombinant vaccinia virus encoding the gp100 melanoma-melanocyte antigen. gp100 human antigen is a wild-type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
